Otonomy Reports Third Quarter 2019 Financial Results and Provides Corporate Update
November 05, 2019 16:13 ET
|
Otonomy, Inc.
Results from three clinical trials expected in 2020 including the Phase 3 trial of OTIVIDEX™ in Ménière’s diseaseBroadest pipeline in neurotology field expanded to include gene therapy collaboration...